Literature DB >> 3035230

Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro.

C L Wilcox, E M Johnson.   

Abstract

Primary sympathetic neuronal cultures were maintained for up to 5 weeks after inoculation with herpes simplex virus (HSV) without evidence of viral infection. Upon deprivation of nerve growth factor, the cultures produced infectious HSV, indicating that the cultures harbored latent HSV. This study demonstrates a function of nerve growth factor in the maintenance of HSV latency.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3035230      PMCID： PMC283698          DOI： 10.1128/JVI.61.7.2311-2315.1987

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  33 in total

1.  Latent infection of the peripheral ANS with herpes simplex virus.

Authors:  R W Price; B J Katz; A L Notkins
Journal:  Nature       Date:  1975-10-23       Impact factor: 49.962

2.  Latent ganglionic infection with herpes simplex virus types 1 and 2: viral reactivation in vivo after neurectomy.

Authors:  M A Walz; R W Price; A L Notkins
Journal:  Science       Date:  1974-06-14       Impact factor: 47.728

3.  Evidence that neurons harbor latent herpes simplex virus.

Authors:  M L Cook; V B Bastone; J G Stevens
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

4.  Isolation of herpesviruses from trigeminal ganglia of man, monkeys, and cats.

Authors:  G Plummer
Journal:  J Infect Dis       Date:  1973-09       Impact factor: 5.226

5.  Recovery of herpes-simplex virus from human trigeminal ganglions.

Authors:  J R Baringer; P Swoveland
Journal:  N Engl J Med       Date:  1973-03-29       Impact factor: 91.245

6.  Herpes simplex virus latency in cultured human cells following treatment with cytosine arabinoside.

Authors:  F J O'Neill; R J Goldberg; F Rapp
Journal:  J Gen Virol       Date:  1972-02       Impact factor: 3.891

7.  Tissue culture assay of nerve growth factor and of the specific antiserum.

Authors:  E L Fenton
Journal:  Exp Cell Res       Date:  1970-03       Impact factor: 3.905

8.  The nerve growth factor: purification as a 30,000-molecular-weight protein.

Authors:  V Bocchini; P U Angeletti
Journal:  Proc Natl Acad Sci U S A       Date:  1969-10       Impact factor: 11.205

9.  Herpesvirus hominis: isolation from human trigeminal ganglion.

Authors:  F O Bastian; A S Rabson; C L Yee; T S Tralka
Journal:  Science       Date:  1972-10-20       Impact factor: 47.728

10.  Herpes simplex virus-host cell relationships in organized cultures of mammalian nerve tissues.

Authors:  L A Feldman; R D Sheppard; M B Bornstein
Journal:  J Virol       Date:  1968-06       Impact factor: 5.103
View more
  74 in total

1.  Analysis of HSV Viral Reactivation in Explants of Sensory Neurons.

Authors:  Jesse H Arbuckle; Anne-Marie W Turner; Thomas M Kristie
Journal:  Curr Protoc Microbiol       Date:  2014-11-03

Review 2.  Neurovirological methods and their applications.

Authors:  P G E Kennedy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

3.  HSV-1 gene expression from reactivated ganglia is disordered and concurrent with suppression of latency-associated transcript and miRNAs.

Authors:  Te Du; Guoying Zhou; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

4.  Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro.

Authors:  C L Wilcox; E M Johnson
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

5.  An Immortalized Human Dorsal Root Ganglion Cell Line Provides a Novel Context To Study Herpes Simplex Virus 1 Latency and Reactivation.

Authors:  Nikki M Thellman; Carolyn Botting; Zachary Madaj; Steven J Triezenberg
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

6.  TOP2β-Dependent Nuclear DNA Damage Shapes Extracellular Growth Factor Responses via Dynamic AKT Phosphorylation to Control Virus Latency.

Authors:  Hui-Lan Hu; Lora A Shiflett; Mariko Kobayashi; Moses V Chao; Angus C Wilson; Ian Mohr; Tony T Huang
Journal:  Mol Cell       Date:  2019-03-28       Impact factor: 17.970

7.  Induction of cellular transcription factors in trigeminal ganglia of mice by corneal scarification, herpes simplex virus type 1 infection, and explantation of trigeminal ganglia.

Authors:  T Valyi-Nagy; S Deshmane; A Dillner; N W Fraser
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

8.  The promoter of the latency-associated transcripts of herpes simplex virus type 1 contains a functional cAMP-response element: role of the latency-associated transcripts and cAMP in reactivation of viral latency.

Authors:  D A Leib; K C Nadeau; S A Rundle; P A Schaffer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

9.  Topical treatment with nerve growth factor in an animal model of herpetic keratitis.

Authors:  Alessandro Lambiase; Marco Coassin; Nicola Costa; Paolo Lauretti; Alessandra Micera; Emiliano Ghinelli; Luigi Aloe; Paolo Rama; Stefano Bonini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-05-04       Impact factor: 3.117

10.  Characterization of a nerve growth factor-inducible cellular activity that enhances herpes simplex virus type 1 gene expression and replication of an ICP0 null mutant in cells of neural lineage.

Authors:  R Jordan; J Pepe; P A Schaffer
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.